Product naming should support identification without being extended into unsupported performance or clinical claims
The samples were then subjected to homogenisation using liquid nitrogen
However, Brello currently offers injectable-only options, so if non-injectable administration is a priority, a different provider is necessary
Growth in the biosimilars market is mainly driven by factors such as the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness
The three dominant insulin manufacturers Novo Nordisk, Eli Lilly, and Sanofi each maintain proprietary pen injector systems: FlexPen, KwikPen, and SoloStar respectively
Other medications designed to help reduce alcohol intake naltrexone and acamprosate act on the central nervous system, said DiFeliceantonio, the studys corresponding author